Kenya Yoshida

1.3k total citations
30 papers, 1.1k citations indexed

About

Kenya Yoshida is a scholar working on Molecular Biology, Hepatology and Epidemiology. According to data from OpenAlex, Kenya Yoshida has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 12 papers in Hepatology and 8 papers in Epidemiology. Recurrent topics in Kenya Yoshida's work include Fibroblast Growth Factor Research (12 papers), Liver physiology and pathology (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Kenya Yoshida is often cited by papers focused on Fibroblast Growth Factor Research (12 papers), Liver physiology and pathology (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Kenya Yoshida collaborates with scholars based in Japan, United States and Germany. Kenya Yoshida's co-authors include Hideji Nakamura, Hirayuki Enomoto, Yoshihiko Kishima, Mitsunari Yamamoto, Yorihide Okuda, Hirokazu Uyama, Hiroaki Ito, Yoshinori Hasegawa, Mitsuo Sato and Masashi Kondo and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Cancer Research.

In The Last Decade

Kenya Yoshida

29 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenya Yoshida Japan 16 802 188 160 130 119 30 1.1k
Grant C. Sellar United Kingdom 16 731 0.9× 142 0.8× 160 1.0× 57 0.4× 91 0.8× 21 1.1k
Isao Matsuura United States 20 1.2k 1.5× 127 0.7× 513 3.2× 70 0.5× 86 0.7× 40 1.5k
Miryam Müller Germany 11 598 0.7× 448 2.4× 251 1.6× 85 0.7× 70 0.6× 15 965
Cong S. Zong United States 17 825 1.0× 168 0.9× 495 3.1× 18 0.1× 93 0.8× 24 1.3k
Frankie Chi Fat Ko Hong Kong 17 544 0.7× 192 1.0× 130 0.8× 26 0.2× 48 0.4× 29 775
I‐Chu Tseng United States 13 256 0.3× 138 0.7× 89 0.6× 81 0.6× 43 0.4× 15 630
Mariagrazia de Palo Italy 4 580 0.7× 148 0.8× 359 2.2× 37 0.3× 67 0.6× 6 834
Bo Hwa Sohn South Korea 19 812 1.0× 333 1.8× 269 1.7× 101 0.8× 139 1.2× 30 1.3k
Ren Zhao China 21 642 0.8× 344 1.8× 529 3.3× 23 0.2× 192 1.6× 56 1.3k
Lisa Ley United States 14 273 0.3× 108 0.6× 326 2.0× 26 0.2× 89 0.7× 30 655

Countries citing papers authored by Kenya Yoshida

Since Specialization
Citations

This map shows the geographic impact of Kenya Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenya Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenya Yoshida more than expected).

Fields of papers citing papers by Kenya Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenya Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenya Yoshida. The network helps show where Kenya Yoshida may publish in the future.

Co-authorship network of co-authors of Kenya Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Kenya Yoshida. A scholar is included among the top collaborators of Kenya Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenya Yoshida. Kenya Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Elshazley, Momen, Mitsuo Sato, Tetsunari Hase, et al.. (2012). The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma. International Journal of Cancer. 131(12). 2820–2831. 63 indexed citations
2.
Yoshida, Kenya, Mitsuo Sato, Tetsunari Hase, et al.. (2012). TIMELESS is overexpressed in lung cancer and its expression correlates with poor patient survival. Cancer Science. 104(2). 171–177. 51 indexed citations
3.
Hase, Tetsunari, Mitsuo Sato, Kenya Yoshida, et al.. (2011). Pivotal role of epithelial cell adhesion molecule in the survival of lung cancer cells. Cancer Science. 102(8). 1493–1500. 26 indexed citations
4.
Hase, Tetsunari, Mitsuo Sato, Kenya Yoshida, et al.. (2011). Abstract 1657: A pivotal role for epithelial cell adhesion molecule (EpCAM) in survival of lung cancer cells. Cancer Research. 71(8_Supplement). 1657–1657. 1 indexed citations
5.
Sato, Mitsuo, Yoshihiro Takeyama, Momen Elshazley, et al.. (2011). Transient but Not Stable ZEB1 Knockdown Dramatically Inhibits Growth of Malignant Pleural Mesothelioma Cells. Annals of Surgical Oncology. 19(S3). 634–645. 5 indexed citations
6.
Takeyama, Yoshihiro, Mitsuo Sato, Tetsunari Hase, et al.. (2010). Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells. Cancer Letters. 296(2). 216–224. 131 indexed citations
7.
Enomoto, Hirayuki, Hideji Nakamura, Weidong Liu, et al.. (2009). Hepatoma‐derived growth factor is induced in liver regeneration. Hepatology Research. 39(10). 988–997. 15 indexed citations
8.
Uyama, Hirokazu, Hideji Nakamura, Eijiro Hayashi, et al.. (2007). Triple therapy of initial high‐dose interferon with ribavirin and amantadine for patients with chronic hepatitis C. Hepatology Research. 37(5). 325–330. 2 indexed citations
9.
Yoshida, Kenya, Yasuhiko Tomita, Yorihide Okuda, et al.. (2006). Hepatoma-Derived Growth Factor Is a Novel Prognostic Factor for Hepatocellular Carcinoma. Annals of Surgical Oncology. 13(2). 159–167. 72 indexed citations
10.
Zhou, Zhiwei, Yoichi Yamamoto, Fuminobu Sugai, et al.. (2004). Hepatoma-derived Growth Factor Is a Neurotrophic Factor Harbored in the Nucleus. Journal of Biological Chemistry. 279(26). 27320–27326. 61 indexed citations
11.
Uyama, Hirokazu, Hirayuki Enomoto, Yoshihiko Kishima, et al.. (2004). A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.. PubMed. 50(54). 2112–6. 4 indexed citations
12.
Yoshida, Kenya, Yoshihiko Kishima, Hirayuki Enomoto, et al.. (2004). Circulating auto-antibody against hepatoma-derived growth factor (HDGF) in patients with ulcerative colitis.. PubMed. 51(56). 470–5. 4 indexed citations
13.
Okuda, Yorihide, Hideji Nakamura, Kenya Yoshida, et al.. (2003). Hepatoma‐derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor. Cancer Science. 94(12). 1034–1041. 76 indexed citations
14.
Mori, Masahide, Hiroshi Morishita, Hideji Nakamura, et al.. (2003). Hepatoma-Derived Growth Factor Is Involved in Lung Remodeling by Stimulating Epithelial Growth. American Journal of Respiratory Cell and Molecular Biology. 30(4). 459–469. 34 indexed citations
15.
Yoshida, Kenya, Hideji Nakamura, Yorihide Okuda, et al.. (2003). Expression of hepatoma‐derived growth factor in hepatocarcinogenesis. Journal of Gastroenterology and Hepatology. 18(11). 1293–1301. 43 indexed citations
16.
Nakamura, Hideji, Toshifumi Kuroda, Mitsunari Yamamoto, et al.. (2003). Interferon treatment for patients with chronic hepatitis C infected with high viral load of genotype 2 virus.. PubMed. 49(47). 1373–6. 6 indexed citations
17.
Kishima, Yoshihiko, Hiroyasu Yamamoto, Kenya Yoshida, et al.. (2002). Hepatoma-derived Growth Factor Stimulates Cell Growth after Translocation to the Nucleus by Nuclear Localization Signals. Journal of Biological Chemistry. 277(12). 10315–10322. 110 indexed citations
18.
Enomoto, Hirayuki, Kenya Yoshida, Yoshihiko Kishima, Yorihide Okuda, & Hideji Nakamura. (2002). Participation of hepatoma-derived growth factor in the regulation of fetal hepatocyte proliferation. Journal of Gastroenterology. 37(S14). 158–161. 17 indexed citations
19.
Nakamura, Hideji, Kenya Yoshida, Kazuhiro Ikegame, et al.. (2002). Antibodies against hepatoma-derived growth factor and mucosal repair in ulcerative colitis. Journal of Gastroenterology. 37(S14). 8–14. 10 indexed citations
20.
Ikegame, Kazuhiro, Mitsunari Yamamoto, Yoshihiko Kishima, et al.. (1999). A New Member of a Hepatoma-Derived Growth Factor Gene Family Can Translocate to the Nucleus. Biochemical and Biophysical Research Communications. 266(1). 81–87. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grant C. Sellar Breakdown of academic impact, for papers by Isao Matsuura Breakdown of academic impact, for papers by Miryam Müller Breakdown of academic impact, for papers by Cong S. Zong Breakdown of academic impact, for papers by Frankie Chi Fat Ko Breakdown of academic impact, for papers by I‐Chu Tseng Breakdown of academic impact, for papers by Mariagrazia de Palo Breakdown of academic impact, for papers by Bo Hwa Sohn Breakdown of academic impact, for papers by Ren Zhao Breakdown of academic impact, for papers by Lisa Ley
Rankless by CCL
2026